|
|
Volumn 5, Issue 3, 2005, Pages 167-168
|
|
Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
DACARBAZINE;
DRUG DERIVATIVE;
TEMOZOLOMIDE;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
BRAIN TUMOR;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
GLIOBLASTOMA;
HUMAN;
METHODOLOGY;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
RADIOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BRAIN NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
DACARBAZINE;
GLIOBLASTOMA;
HUMANS;
RADIOTHERAPY;
TREATMENT OUTCOME;
|
|
EID: 24944531836
PISSN: 15284042
EISSN: None
Source Type: Journal
DOI: 10.1007/s11910-005-0043-y Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
